News (36)

Transcript : Acerus Pharmaceuticals Corporation - Shareholder/Analyst Call
Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™ AQ
Transcript : Acerus Pharmaceuticals Corporation - Shareholder/Analyst Call
Bank of Montreal : BMO's Mona Malone Wins 2021 Report on Business Best Executive Award AQ
Acerus Pharmaceuticals : Announces Details of Previously Completed Rights Offering BU
TMX : Committee to Chart the Future of Corporate Governance in Canada PU
Transcript : Acerus Pharmaceuticals Corporation, Q1 2020 Earnings Call, May 12, 2020
Acerus Pharmaceuticals : Appoints Dr. Geoff Cotton to Its Board of Directors PU
Acerus Pharmaceuticals Corporation announced that it has received CAD 4.530001 million in funding from First Generation Capital Inc. CI
Acerus Pharmaceuticals : Announces Executive Leadership Change BU
Trimel Pharmaceuticals : Acerus Appoints Mr. Mark Lievonen to its Board of Directors PU
Trimel Pharmaceuticals : Acerus Announces Voting Results for the 2017 Annual General Meeting PU
Acerus Appoints Mr. Luc Mainville to Its Board of Directors BU
Acerus Announces Voting Results for the 2016 Annual General Meeting BU
First Generation Capital Inc. Enters Into Agreement to Purchase Common Shares of Acerus Pharmaceuticals Corporation MW
Acerus Announces Changes to Board of Directors BU
Trimel Pharmaceuticals : Announces Voting Results For 2015 Annual General And Special Shareholder's Meeting PU
Trimel Pharmaceuticals : Announces Voting Results for 2015 Annual General and Special Shareholder’s Meeting BU
Trimel Pharmaceuticals : Reports Third Quarter 2014 Financials Results PU
Trimel Pharmaceuticals : Reports Third Quarter 2014 Financial Results MW
First Generation Capital Inc. Converts a Portion of Previously Issued Convertible Note of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals : Provides Corporate Update and Second Quarter 2014 Financial Results MW
First Generation Capital Inc. Amends Previously Issued Convertible Note of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals : Completes Private Placement Of Common Shares PU
First Generation Capital Inc. Acquires Convertible Note of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals : Announces Voting Results For 2014 Annual General And Special Shareholders’ Meeting PU
Trimel Pharmaceuticals : Announces Voting Results for 2014 Annual General and Special Shareholders' Meeting MW
Trimel Reports Fourth Quarter and Full Year 2013 Financial Results MW
First Generation Capital Inc. Acquires Shares of Trimel Pharmaceuticals Corporation MW
Trimel Announces $10.5 Million Private Placement of Common Shares MW
Trimel Announces Appointment of Tom Rossi to Its Board of Directors MW
Trimel Announces Retirement of Chair and Appointment of New Chair MW
Trimel Pharmaceuticals Corporation Announces Board Changes, Effective from January 15, 2014 CI
First Generation Capital Inc. Acquires Shares of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals Corporation Announces Appointment Ian Ihnatowycz to Board of Directors CI
Ian O. Ihnatowycz to Step Down from AGF Management Limited as Director, Effective May 7, 2013 CI

Companies (1)

B2EN CO., LTD. 36 M $
Logo B2En Co., Ltd.

B2En Co Ltd, formerly Sangsangin Ian No.1 Special Purpose Acquisition Co Ltd is a Korea-based company principally engaged in the data consulting and data solution business. The Company operates its business through three segments. The Big Data segment eng ...


Insiders

Picture Ian Ihnatowycz
Ian Ihnatowycz

Ian Orest Ihnatowycz was the founder of Acuity Investment Management, Inc. (founded in 1990) where he held the title of President & Chief Executive Officer from 1991 to 2010.
He is currently the President & Chief Executive Officer at Generation Capital, Inc. (since 2011), First Generation Capital, Inc. (since 2011), and Chairman at Acerus Pharmaceuticals Corp.
(since 2014).
He also serves as a Director at Kardium, Inc., The Atlantic Council of the United States, The Royal Conservatory of Music, Real Imaging Holdings Ltd., Myca Health Inc., Real Imaging Ltd., Fulcrum Management Solutions Ltd., Wellbox, Inc., and IKOMED Technologies, Inc. Mr. Ihnatowycz previously held the position of President & Chief Executive Officer at Acuity Growth & Income Trust, Acuity Small Cap Corp., and Acuity Funds Ltd.
(from 1990 to 2011).
He also served as a Director at AGF Management Ltd., Zymeworks BC, Inc., and The Investment Funds Institute of Canada.
Mr. Ihnatowycz obtained his undergraduate degree from the University of Toronto in 1971 and an MBA from the Richard Ivey School of Business.



Picture Ian Rickwood
Ian Rickwood

Ian Rickwood is currently the Chief Executive Officer of Henley Healthcare, Inc., and the CEO of Henley Ventures.
He is also a Director at Eastern Quarry Ltd., IPSX Group Ltd., Henley Property Finance 1 Ltd., Hentop 308 Ltd., Hentop 306 Ltd., Topland Henley Healthcare Investments Ltd., Hentop 305 Ltd., Hentop 307 Ltd., Hentop 311 Ltd., Hentop 310 Ltd., Hentop 309 Ltd., Hentop 318A Ltd., Henley Camland Ebbsfleet 801 Ltd., and Henley Camland Ebbsfleet 801H Ltd.
Mr. Rickwood's former position was as the Chief Executive Officer of Benjys Ltd.


Picture Ian James Nicholson
Ian James Nicholson

Ian James Nicholson is currently the Non-Executive Chairman at Bioventix Plc, Director at Casewell Consulting Ltd., Director at Wells Stores Ltd., Non-Executive Director at BenevolentAI SA, Operating Partner at Advent Venture Partners LLP, Trustee at Lifearc, and Operating Partner at Advent Life Sciences LLP.
Previously, he served as the Chief Executive Officer at Chroma Therapeutics Ltd.
from 2004 to 2012, Chief Executive Officer & Director at F2G Ltd.
from 2013 to 2021, Director at Consort Medical Ltd.
from 2012 to 2020, Non-Executive Director at Symphogen A, Director at The Bioindustry Association, Director at Macrotarg Ltd., Independent Non-Executive Director at Clinigen Ltd.
from 2012 to 2021, and Senior Vice President-Business Development at Celltech Group Plc from 2000 to 2004.
He also held positions as Principal at Lonza Group AG, Oxford Asymmetry International Plc, and GE Healthcare Ltd.
(United Kingdom).
Mr. Nicholson holds an MBA from Boston University and an undergraduate degree from University College London.


Picture Ian Bliss
Ian Bliss

Ian C.
Bliss
is currently the President, Chief Executive Officer & Director at Northern Shield Resources, Inc. He previously served as an Independent Director at Nouveau Monde Graphite, Inc. from 2013 to 2016.
Mr. Bliss obtained his undergraduate degree from the University of New Brunswick.




Picture Ian S. Tharp
Ian S. Tharp

Mr. Ian S.
Tharp
is a Research Analyst at CIBC World Markets, Inc. Prior to joining CIBC, Mr. Tharp was Senior Analyst at Dundee Securities, since October 2007.
Before that, he was a Partner & Portfolio Manager at The Quantum Leap Co., since January 2000.
Previously, he was Marketing Manager-Western Region at TransAlta Energy Marketing Limited and Natural Gas Trader at TransCanada Gas Services, Inc. Mr. Tharp graduated from The University of Western Ontario.
He is a Chartered Financial Analyst.


Picture Ian Campbell
Ian Campbell

Ian Campbell is currently the Chairman, Chief Executive Officer & Director at LaSalle Exploration Corp.
He is also a Director at Harfang Exploration, Inc. Additionally, he is a Member of the Association of Professional Geoscientists of Ontario and the Professional Geoscientists of Ontario.
In the past, Mr. Campbell served as the President, Chief Executive Officer & Director at Temex Resources Corp.
from 2005 to 2015.
He was also a Project Manager at Pan American Silver Corp.
Furthermore, he held the position of Vice President-Exploration at Avalon Advanced Materials, Inc. from 1996 to 2001.
Lastly, he worked as a Projects Manager at Tahoe Resources, Inc. from 2015 to 2018.
Mr. Campbell obtained his undergraduate degree from the University of Lakehead in 1982.


Picture Ian Meakin
Ian Meakin

Ian Meakin is a member of The Chartered Institute of Marketing, and has previously worked as Vice President-Marketing at Sun Microsystems, Inc. and Pegasystems Software Ltd.
He also worked as Vice President-Marketing at Cellcrypt Ltd.
from 2000 to 2012.
Mr. Meakin completed his undergraduate degree at the University of Bristol.
Currently, Mr. Meakin is employed at The Chartered Institute of Marketing.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW